74.18
price down icon0.58%   -0.43
after-market Dopo l'orario di chiusura: 75.66 1.48 +2.00%
loading
Precedente Chiudi:
$74.61
Aprire:
$74.61
Volume 24 ore:
593.39K
Relative Volume:
0.99
Capitalizzazione di mercato:
$3.73B
Reddito:
$379.25M
Utile/perdita netta:
$-77.34M
Rapporto P/E:
-46.01
EPS:
-1.6122
Flusso di cassa netto:
$-27.87M
1 W Prestazione:
-1.79%
1M Prestazione:
+42.00%
6M Prestazione:
+64.04%
1 anno Prestazione:
+77.46%
Intervallo 1D:
Value
$73.26
$74.83
Intervallo di 1 settimana:
Value
$73.12
$76.02
Portata 52W:
Value
$36.86
$76.02

Mirum Pharmaceuticals Inc Stock (MIRM) Company Profile

Name
Nome
Mirum Pharmaceuticals Inc
Name
Telefono
650-667-4085
Name
Indirizzo
989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY
Name
Dipendente
349
Name
Cinguettio
@mirumpharma
Name
Prossima data di guadagno
2024-11-04
Name
Ultimi documenti SEC
Name
MIRM's Discussions on Twitter

Confronta MIRM con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
MIRM
Mirum Pharmaceuticals Inc
74.18 3.73B 379.25M -77.34M -27.87M -1.6122
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.93 102.81B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
453.54 58.59B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
567.22 61.25B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
733.66 43.23B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
318.73 36.53B 3.81B -644.79M -669.77M -6.24

Mirum Pharmaceuticals Inc Stock (MIRM) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-08-11 Ripresa Stifel Buy
2025-05-19 Ripresa H.C. Wainwright Buy
2024-04-17 Iniziato Stifel Buy
2023-12-18 Reiterato H.C. Wainwright Buy
2023-11-20 Ripresa JP Morgan Overweight
2023-11-13 Iniziato Morgan Stanley Overweight
2023-10-24 Iniziato Cantor Fitzgerald Overweight
2023-10-17 Ripresa Evercore ISI Outperform
2023-09-20 Iniziato JMP Securities Mkt Outperform
2022-09-01 Iniziato Citigroup Buy
2021-09-20 Iniziato JP Morgan Overweight
2020-08-07 Aggiornamento Raymond James Outperform → Strong Buy
2020-08-03 Iniziato H.C. Wainwright Buy
2020-07-31 Iniziato Piper Sandler Overweight
2020-06-25 Iniziato Robert W. Baird Outperform
2019-08-12 Iniziato Citigroup Buy
2019-08-12 Iniziato Evercore ISI Outperform
2019-08-12 Iniziato Guggenheim Buy
2019-08-12 Iniziato ROTH Capital Buy
2019-08-12 Iniziato Raymond James Outperform
Mostra tutto

Mirum Pharmaceuticals Inc Borsa (MIRM) Ultime notizie

pulisher
Sep 03, 2025

Mirum Pharmaceuticals stock reaches all-time high of 75.8 USD - Investing.com

Sep 03, 2025
pulisher
Sep 03, 2025

Real time scanner hits for Mirum Pharmaceuticals Inc. explained2025 Short Interest & Daily Profit Focused Screening - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Does Mirum Pharmaceuticals Inc. show high probability of reboundJuly 2025 Spike Watch & Verified Swing Trading Watchlist - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Signal strength of Mirum Pharmaceuticals Inc. stock in tech scannersEarnings Recap Report & Capital Efficient Trade Techniques - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Multi factor analysis applied to Mirum Pharmaceuticals Inc.Weekly Stock Report & Risk Controlled Swing Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Chart overlay techniques for tracking Mirum Pharmaceuticals Inc.Market Performance Recap & Smart Money Movement Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Forecasting Mirum Pharmaceuticals Inc. price range with options dataPortfolio Gains Report & Technical Confirmation Trade Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Is Mirum Pharmaceuticals Inc. impacted by rising ratesSwing Trade & Real-Time Buy Zone Alerts - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

Is Mirum Pharmaceuticals Inc. showing signs of accumulationMarket Movement Recap & High Accuracy Buy Signal Tips - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Does Mirum Pharmaceuticals Inc. have strong fundamentalsJuly 2025 Breakouts & Risk Managed Investment Strategies - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

How high can Mirum Pharmaceuticals Inc. stock goEarnings Risk Report & Free Real-Time Volume Trigger Notifications - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Sentiment analysis tools applied to Mirum Pharmaceuticals Inc.2025 Key Lessons & Daily Technical Forecast Reports - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

What are Mirum Pharmaceuticals Inc.’s earnings expectationsPortfolio Growth Summary & High Conviction Buy Zone Alerts - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Strategies to average down on Mirum Pharmaceuticals Inc.July 2025 Highlights & Free Low Drawdown Momentum Trade Ideas - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Alagille Syndrome Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Takeda, Mirum Pharmaceuticals, Albireo - Barchart.com

Sep 02, 2025
pulisher
Sep 02, 2025

How to interpret RSI for Mirum Pharmaceuticals Inc. stockQuarterly Profit Report & Real-Time Volume Analysis - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

What indicators show strength in Mirum Pharmaceuticals IncWeekly Trend Report & Capital Efficiency Focused Strategies - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Using Ichimoku Cloud for Mirum Pharmaceuticals Inc. technicals2025 Bull vs Bear & Risk Adjusted Buy and Sell Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Applying big data sentiment scoring on Mirum Pharmaceuticals Inc.July 2025 Decliners & Fast Entry Momentum Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Is Mirum Pharmaceuticals Inc. stock forming a triangle pattern2025 Major Catalysts & Advanced Technical Analysis Signals - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Will Mirum Pharmaceuticals Inc. benefit from seasonalityEarnings Risk Report & Capital Protection Trading Alerts - khodrobank.com

Sep 02, 2025
pulisher
Sep 01, 2025

Will Mirum Pharmaceuticals Inc. stock hit new highs in YEAR2025 Volatility Report & Safe Swing Trade Setup Alerts - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

What is Mirum Pharmaceuticals Inc. s debt to equity ratio2025 Winners & Losers & AI Powered Buy and Sell Recommendations - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

What’s next for Mirum Pharmaceuticals Inc. stock pricePortfolio Profit Report & Verified Swing Trading Watchlists - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Trend Dashboard Flags Mirum Pharmaceuticals Inc. As Potential Swing Trade getLinesFromResByArray error: size == 0 - thegnnews.com

Sep 01, 2025
pulisher
Sep 01, 2025

Can Mirum Pharmaceuticals Inc. deliver consistent dividends2025 Stock Rankings & Free Community Consensus Stock Picks - beatles.ru

Sep 01, 2025
pulisher
Aug 31, 2025

Applying Elliott Wave Theory to Mirum Pharmaceuticals Inc.2025 Momentum Check & Free Community Supported Trade Ideas - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

What indicators show strength in Mirum Pharmaceuticals Inc.Earnings Miss & Stock Portfolio Risk Management - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Will Mirum Pharmaceuticals Inc. stock recover after recent dropInsider Buying & Expert Verified Stock Movement Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Using Bollinger Bands to evaluate Mirum Pharmaceuticals Inc.2025 Winners & Losers & Long-Term Growth Plans - Newser

Aug 31, 2025
pulisher
Aug 30, 2025

Mirum Pharmaceuticals Inc. Shows Risk Reward Favoring UpsideJuly 2025 Volume & Advanced Technical Signal Analysis - beatles.ru

Aug 30, 2025
pulisher
Aug 30, 2025

Visual trend scoring systems applied to Mirum Pharmaceuticals Inc.Trade Entry Summary & Weekly Watchlist of Top Performers - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Mirum Pharmaceuticals (NASDAQ:MIRM) Rating Lowered to "Buy" at Wall Street Zen - MarketBeat

Aug 30, 2025

Mirum Pharmaceuticals Inc Azioni (MIRM) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Mirum Pharmaceuticals Inc Azioni (MIRM) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Peetz Christopher
CHIEF EXECUTIVE OFFICER
Aug 11 '25
Option Exercise
2.94
40,000
117,440
178,641
Peetz Christopher
CHIEF EXECUTIVE OFFICER
Aug 11 '25
Sale
62.00
40,000
2,480,000
138,641
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Capitalizzazione:     |  Volume (24 ore):